到 2030 年亚太地区生物塑料和生物聚合物市场预测 – 区域分析 – 按产品类型(聚乙烯、聚对苯二甲酸乙二醇酯、聚乳酸、聚对苯二甲酸丙二醇酯、聚己二酸对苯二甲酸丁二醇酯、聚丁二酸丁二醇酯、纤维素、共混物等)和最终用途工业(包装、消费品、汽车、纺织、建筑、医疗、农业等)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2030


No. of Pages: 137    |    Report Code: BMIRE00029219    |    Category: Chemicals and Materials

Asia Pacific Bioplastics and Biopolymers Market

亚太地区生物塑料和生物聚合物市场预计将从2023年的28.9007亿美元增长到2030年的61.7113亿美元。预计2023年至2030年复合年增长率为11.4%。< /strong>

生物降解塑料在生物医学应用中的日益普及推动亚太地区生物塑料和生物聚合物市场

在生物医学行业,生物塑料高度适用于用于烧伤和伤口的皮肤替代品、组织工程支架、骨骼重建、神经和牙龈重建、药物释放系统、血管生长和支架覆盖。此外,医院和手术室的医疗专业人员正在使用无毒的可生物降解的生物塑料缝合线(通常称为缝线)。可生物降解塑料也用于医疗器械。例如,在重建手术期间用于帮助骨骼愈合的别针、平头钉和螺钉都是由生物塑料制成的。片剂和霜剂的容器也可以利用生物塑料生产。此外,在牙科行业,基于生物塑料的纳米纤维素已用于人类牙科组织再生,该纳米纤维素由木葡糖醋杆菌菌株的微生物纤维素产生。可生物降解塑料,例如PLA;聚己内酯;聚乳酸-乙醇酸 (PLGA) 和聚羟基脂肪酸酯 (PHA) 及其共聚物应用于以人为中心的生物医学应用。例如,PLA由于其生物相容性和在人体内的生物溶解性而被广泛应用于医疗应用,降解后酯主链水解产生无害且无毒的化合物。 PLA 及其共聚物还用于伤口处理应用,包括制造手术缝合线、预防术后粘连以及愈合牙科伤口。 PLA因其完全生物降解性、更好的封装性、生物相容性和低毒性而被用于药物递送系统。可生物降解塑料还用于骨科应用,以避免进行第二次外科手术以去除不必要的硬件。

随着原材料来源的减少,预计传统塑料在未来将变得更加昂贵。 PLA 及其共聚物可用于各种伤口处理应用,例如愈合牙科伤口、制作手术缝合线以及防止术后粘连。由于其封装能力、低毒性和生物相容性,PLA也已应用于药物输送系统。因此,预计所有上述因素将在未来几年为生物塑料和生物聚合物市场提供利润丰厚的机会。

亚太地区生物塑料和生物聚合物市场概览

亚太地区生物塑料和生物聚合物市场分为澳大利亚、中国、印度、日本、韩国和亚太其他地区。包装行业的增长、政府的支持等因素鼓励采用环保产品的政策、日益严重的环境问题以及主要市场参与者不断增加的投资正在推动该地区生物塑料和生物聚合物市场的增长。由于环境相关法规的增加和政府鼓励环保意识的举措,消费者越来越多地转向生物基塑料。事实证明,对传统塑料的禁令数量不断增加是区域市场增长的主要推动力。由于印度和中国等国家对环境问题的关注,公司正在转向生物塑料和生物聚合物,预计这将帮助他们获得更高的消费市场份额。

亚太地区生物塑料和生物聚合物市场收入到 2030 年的预测(百万美元)

亚太地区生物塑料和生物聚合物市场细分

亚太地区生物塑料和生物聚合物市场细分为产品类型、最终用途行业和国家。

根据产品类型,亚太地区生物塑料和生物聚合物市场细分为聚乙烯、聚对苯二甲酸乙二醇酯、聚乳酸、聚对苯二甲酸丙二醇酯、聚己二酸对苯二甲酸丁二醇酯、聚丁二酸丁二醇酯、纤维素、混合物等。到2023年,共混物领域将占据亚太地区生物塑料和生物聚合物市场的最大份额。

根据最终用途行业,亚太地区生物塑料和生物聚合物市场分为包装、消费品、汽车、纺织品、建筑、医疗、农业等。到 2023 年,包装领域在亚太地区生物塑料和生物聚合物市场中占据最大份额。

按国家/地区划分,亚太地区生物塑料和生物聚合物市场分为澳大利亚、中国、印度、日本、韩国,以及亚太地区其他地区。 2023 年,中国将主导亚太地区生物塑料和生物聚合物市场。

阿科玛 SA、巴斯夫 SE、Braskem SA、Cardia Bio Plastics Australia Pty Ltd、Corbion NV、伊士曼化学 Co、三菱化学控股Corp、三井化学公司、Novamont SpA 和沙特基础工业公司是亚太地区生物塑料和生物聚合物市场的领先公司。



Asia Pacific Bioplastics and Biopolymers Strategic Insights

Strategic insights for Asia Pacific Bioplastics and Biopolymers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-bioplastics-and-biopolymers-market-strategic-framework.webp
Get more information on this report

Asia Pacific Bioplastics and Biopolymers Report Scope

Report Attribute Details
Market size in 2023 US$ 2,890.07 Million
Market Size by 2030 US$ 6,171.13 Million
Global CAGR (2023 - 2030) 11.4%
Historical Data 2021-2022
Forecast period 2024-2030
Segments Covered By 产品类型
  • 聚乙烯
  • 聚对苯二甲酸乙二醇酯
  • 聚乳酸
  • 聚对苯二甲酸丙二醇酯
  • 聚己二酸丁二醇酯
  • 聚丁二酸丁二醇酯
  • 纤维素
  • 共混物
By 最终用途行业
  • 包装
  • 消费品
  • 汽车
  • 纺织
  • 建筑
  • 医疗
  • 农业
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Arkema SA
  • BASF SE
  • Braskem SA
  • Cardia Bioplastics Australia Pty Ltd
  • Corbion NV
  • Eastman Chemical Co
  • Mitsubishi Chemical Holdings Corp
  • Mitsui Chemicals Inc
  • Novamont SpA
  • Saudi Basic Industries Corp
  • Get more information on this report

    Asia Pacific Bioplastics and Biopolymers Regional Insights

    The regional scope of Asia Pacific Bioplastics and Biopolymers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-bioplastics-and-biopolymers-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Bioplastics and Biopolymers Market

    1. Arkema SA
    2. BASF SE
    3. Braskem SA
    4. Cardia Bioplastics Australia Pty Ltd
    5. Corbion NV
    6. Eastman Chemical Co
    7. Mitsubishi Chemical Holdings Corp
    8. Mitsui Chemicals Inc
    9. Novamont SpA
    10. Saudi Basic Industries Corp
    Frequently Asked Questions
    How big is the Asia Pacific Bioplastics and Biopolymers Market?

    The Asia Pacific Bioplastics and Biopolymers Market is valued at US$ 2,890.07 Million in 2023, it is projected to reach US$ 6,171.13 Million by 2030.

    What is the CAGR for Asia Pacific Bioplastics and Biopolymers Market by (2023 - 2030)?

    As per our report Asia Pacific Bioplastics and Biopolymers Market, the market size is valued at US$ 2,890.07 Million in 2023, projecting it to reach US$ 6,171.13 Million by 2030. This translates to a CAGR of approximately 11.4% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Bioplastics and Biopolymers Market report typically cover these key segments-

  • 产品类型 (聚乙烯, 聚对苯二甲酸乙二醇酯, 聚乳酸, 聚对苯二甲酸丙二醇酯, 聚己二酸丁二醇酯, 聚丁二酸丁二醇酯, 纤维素, 共混物)
  • 最终用途行业 (包装, 消费品, 汽车, 纺织, 建筑, 医疗, 农业)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Bioplastics and Biopolymers Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Bioplastics and Biopolymers Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2030
  • Who are the major players in Asia Pacific Bioplastics and Biopolymers Market?

    The Asia Pacific Bioplastics and Biopolymers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Arkema SA
  • BASF SE
  • Braskem SA
  • Cardia Bioplastics Australia Pty Ltd
  • Corbion NV
  • Eastman Chemical Co
  • Mitsubishi Chemical Holdings Corp
  • Mitsui Chemicals Inc
  • Novamont SpA
  • Saudi Basic Industries Corp
  • Who should buy this report?

    The Asia Pacific Bioplastics and Biopolymers Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Bioplastics and Biopolymers Market value chain can benefit from the information contained in a comprehensive market report.